关于人工智能近期发展的最新更新在QSAR模型中用于针对肺癌的药物发现
Deepanshi Chaudhary1, Chakresh Kumar Jain1
1Department of Biotechnology, Jaypee Institute of Information Technology, A-10, Sector 62, Noida, Uttar Pradesh, 201309, India.
Current topics in medicinal chemistry
|October 23, 2025
概括
由人工智能 (AI) 驱动的定量结构-活动关系 (QSAR) 模型通过克服开发瓶来加速肺癌药物发现. 这些先进的计算方法是识别和优化肺癌患者新疗法的关键.
科学领域:
- 计算化学和药理学计算化学和药理学
- 瘤学药物发现研究
- 医学中的人工智能
背景情况:
- 肺癌仍然是全球癌症死亡的主要原因之一.
- 迫切需要创新和有针对性的药物发现战略.
- 定量结构-活动关系 (QSAR) 建模为治疗开发提供了一个有前途的途径.
研究的目的:
- 批判性地审查人工智能集成的QSAR在加速肺癌药物发现中的作用.
- 分析最近在多目标方法,机器学习和分子描述器方面的进展.
- 专注于人工智能驱动的QSAR方法的临床翻译.
主要方法:
- 对人工智能驱动的QSAR用于肺癌治疗的最新进展进行分析.
- 评估AI-QSAR如何解决药物开发瓶的问题,例如数据不平衡和ADMET预测.
- 检查突出转化成功的病例研究在肺癌途径的检查.
主要成果:
- 人工智能驱动的QSAR模型在识别和优化肺癌治疗方面显示出重大潜力.
- 机器学习和先进的分子描述器的整合提高了预测准确性.
- AI-QSAR有效地解决了数据不平衡和模型可解释性方面的挑战.
结论:
- 人工智能增强的QSAR方法对于推动肺癌药物发现至关重要.
- 解决目前的差距可以进一步改善这些计算工具的现实应用.
- 未来的方向包括改进AI-QSAR以实现更有效的瘤药物开发.
更多相关视频
10:29Quantitative Structure-Activity Relationship, Activity Prediction, and Molecular Dynamics of Non-nucleotide Reverse Transcriptase Inhibitors
Published on: May 9, 2025
2.2K
05:47In Silico Modeling Method for Computational Aquatic Toxicology of Endocrine Disruptors: A Software-Based Approach Using QSAR Toolbox
Published on: August 28, 2019
14.6K
相关概念视频
01:28Structure-Activity Relationships and Drug Design
1.7K
Drug design is a dynamic field that involves discovering and developing new medications based on specific biological targets. This process heavily relies on structure-activity relationships (SAR) and quantitative structure-activity relationships (QSAR) to guide the design and optimization of efficient drugs.
SAR studies the intricate relationship between a drug's chemical structure and biological activity. It focuses on understanding how modifications to a drug's structure can influence...
SAR studies the intricate relationship between a drug's chemical structure and biological activity. It focuses on understanding how modifications to a drug's structure can influence...
1.7K
02:57Targeted Cancer Therapies
8.6K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
8.6K